New malaria vaccine licensed for use in Ghana
The R21/Matrix-M malaria vaccine, developed by the University of Oxford, has received its first regulatory clearance.
Archives for April 13, 2023
Biogen opts into Alzheimer’s drug candidate from pact with Denali Therapeutics
As part of a $1 billion deal forged in 2020, Biogen has exercised the option to license a treatment candidate for Alzheimer’s disease developed by the US biotech company Denali Therapeutics. The engineered antibody drug is designed to cross into the...
Samsung Ventures invests in Araris Biotech in emerging ADC strategy
Samsung Ventures, the global investment arm of Samsung Group, has invested an undisclosed amount in the Swiss company Araris Biotech. The deal is independent from Araris’ ongoing Series A fundraising and will be used to bankroll the development of...
Study spotlight supplements found to reduce side effects of COVID-19 vaccines
The new study observes a significant association between supplement consumption and vaccination side effects in an Italian adult population, specifically spotlighting the effects of omega-3 and mineral supplement consumption in reducing associated...